AB
AKBA icon

Amalgamated Bank’s Akebia Therapeutics AKBA Stock Holding History

Amalgamated Bank’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,955
Closed -$13K – 1656
2025
Q4 		$13K Buy
7,955
+758
+11% +$1.59K ﹤0.01% 2296
2025
Q3 		$20K Hold
7,197
– – ﹤0.01% 2108
2025
Q2 		$26K Hold
7,197
– – ﹤0.01% 2014
2025
Q1 		$14K Hold
7,197
– – ﹤0.01% 2198
2024
Q4 		$14K Hold
7,197
– – ﹤0.01% 2258
2024
Q3 		$10K Hold
7,197
– – ﹤0.01% 2432
2024
Q2 		$7K Buy
+7,197
New +$8.89K ﹤0.01% 2591
2022
Q2 		– Sell
-24,241
Closed -$17K – 3028
2022
Q1 		$17K Sell
24,241
-1,832
-7% -$3.92K ﹤0.01% 2843
2021
Q4 		$59K Buy
26,073
+1,040
+4% +$2.84K ﹤0.01% 2104
2021
Q3 		$72K Sell
25,033
-732
-3% -$2.09K ﹤0.01% 2108
2021
Q2 		$98K Buy
25,765
+3,381
+15% +$11.4K ﹤0.01% 2121
2021
Q1 		$76K Hold
22,384
– – ﹤0.01% 1564
2020
Q4 		$63K Buy
22,384
+118
+0.5% +$345 ﹤0.01% 1553
2020
Q3 		$56K Buy
22,266
+1,446
+7% +$12.7K ﹤0.01% 1449
2020
Q2 		$283K Buy
20,820
+2,394
+13% +$24.8K 0.01% 1135
2020
Q1 		$140K Sell
18,426
-780
-4% -$6.07K ﹤0.01% 1444
2019
Q4 		$121K Buy
19,206
+1,703
+10% +$8.09K ﹤0.01% 1713
2019
Q3 		$69K Sell
17,503
-210
-1% -$900 ﹤0.01% 1683
2019
Q2 		$86K Buy
17,713
+4,336
+32% +$24.7K ﹤0.01% 1705
2019
Q1 		$110K Buy
13,377
+438
+3% +$3.01K ﹤0.01% 1596
2018
Q4 		$72K Buy
+12,939
New +$101K ﹤0.01% 1544

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Amalgamated Bank's AKBA Position: Q1 2026 in Review

Amalgamated Bank sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 7,955 shares — an estimated $13K sold.

Amalgamated Bank first reported a position in AKBA in Q4 2018 and held it in 21 quarters. The position peaked at $283K in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Amalgamated Bank reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 7,955 Akebia Therapeutics shares in Q1 2026, an estimated $13K.
  • Amalgamated Bank first reported a position in Akebia Therapeutics in Q4 2018 and held it in 21 quarters.
  • Amalgamated Bank's Akebia Therapeutics position peaked at $283K in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.